These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20694748

  • 21. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Dąbrowski M, Kukuła K, Kłopotowski M, Bekta P, Śpiewak M, Mazurkiewicz Ł, Tyczyński P, Orczykowski M, Parma R, Witkowski A.
    Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
    [Abstract] [Full Text] [Related]

  • 22. Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on left-ventricular mechanical dyssynchrony as assessed by phase analysis of gated SPECT myocardial perfusion imaging.
    Chen J, Nagaraj H, Bhambhani P, Kliner DE, Soman P, Garcia EV, Heo J, Iskandrian AE.
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1375-84. PubMed ID: 21863321
    [Abstract] [Full Text] [Related]

  • 23. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X, Yue Y, Wang Y, Deng Y, Liu L, Di Y, Sun S, Chen D, Fan L, Cao J.
    Cardiovasc Ultrasound; 2018 Oct 02; 16(1):23. PubMed ID: 30285887
    [Abstract] [Full Text] [Related]

  • 24. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
    Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H.
    Clin Res Cardiol; 2007 Dec 02; 96(12):864-73. PubMed ID: 17891518
    [Abstract] [Full Text] [Related]

  • 25. Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy.
    Carasso S, Woo A, Yang H, Schwartz L, Vannan MA, Jamorski M, Linghorne M, Wigle ED, Rakowski H.
    J Am Soc Echocardiogr; 2008 May 02; 21(5):493-9. PubMed ID: 17961980
    [Abstract] [Full Text] [Related]

  • 26. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H, Faber L, Gleichmann U.
    Thorac Cardiovasc Surg; 1999 Apr 02; 47(2):94-100. PubMed ID: 10363608
    [Abstract] [Full Text] [Related]

  • 27. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Jassal DS, Neilan TG, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Picard MH, Yoerger DM.
    Eur Heart J; 2006 Aug 02; 27(15):1805-10. PubMed ID: 16774986
    [Abstract] [Full Text] [Related]

  • 28. Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.
    Yao L, Ta S, Wang J, Han C, Lei C, Li W, Li J, Wang B, Zhao X, Liu L.
    Int J Cardiovasc Imaging; 2024 Jul 02; 40(7):1483-1492. PubMed ID: 38709352
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J, Groch L, Meluzín J, Vykypel T, Halámek J, Vitovec J.
    Vnitr Lek; 2006 Apr 02; 52(4):313-20. PubMed ID: 16755987
    [Abstract] [Full Text] [Related]

  • 33. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J, Koh Y, Bak M, Gooley RP, Meredith IT, McCormick LM.
    Heart Lung Circ; 2018 Dec 02; 27(12):1446-1453. PubMed ID: 29129561
    [Abstract] [Full Text] [Related]

  • 34. Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction.
    Tower-Rader A, Betancor J, Popovic ZB, Sato K, Thamilarasan M, Smedira NG, Lever HM, Desai MY.
    J Am Heart Assoc; 2017 Oct 20; 6(10):. PubMed ID: 29054839
    [Abstract] [Full Text] [Related]

  • 35. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
    Lu M, Du H, Gao Z, Song L, Cheng H, Zhang Y, Yin G, Chen X, Ling J, Jiang Y, Wang H, Li J, Huang J, He Z, Zhao S.
    Circ Cardiovasc Interv; 2016 Mar 20; 9(3):e002675. PubMed ID: 26884612
    [Abstract] [Full Text] [Related]

  • 36. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Tsuchikane E, Takeda Y, Kobayashi T, Yachiku K, Nasu K, Kobayashi Y, Matsumoto H, Awata N.
    Circ J; 2003 Sep 20; 67(9):763-7. PubMed ID: 12939552
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An assessment of left atrial function in patients with hypertrophic obstructive cardiomyopathy before and 1 year after septal ablation by two-dimensional speckle tracking echocardiography.
    Fang H, Tang H, Li P, Xiong L, Hu G, Li L, Yu Y, Zhao B.
    Echocardiography; 2017 Mar 20; 34(3):407-414. PubMed ID: 28130861
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.